{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:09:47Z","timestamp":1788322187973,"version":"build-2803163510"},"reference-count":45,"publisher":"CMA Joule Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.9778\/cmajo.20180020","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:35:13Z","timestamp":1536590113000},"page":"E372-E383","source":"Crossref","is-referenced-by-count":17,"title":["Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study"],"prefix":"10.9778","volume":"6","author":[{"given":"Cheri","family":"Deal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Chanoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Rosolowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Child","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"2021051713001937000_6.3.E372.1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/apa.12266","article-title":"Early recognition of growth abnormalities permitting early intervention","volume":"102","author":"Haymond","year":"2013","journal-title":"Acta Paediatr"},{"key":"2021051713001937000_6.3.E372.2","first-page":"1","article-title":"Growth hormone deficiency: an update","volume":"38","author":"Aud\u00ed","year":"2013","journal-title":"Minerva Endocrinol"},{"key":"2021051713001937000_6.3.E372.3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000350829","article-title":"Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study","volume":"79","author":"Deal","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"2021051713001937000_6.3.E372.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2187"},{"key":"2021051713001937000_6.3.E372.5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000452973","article-title":"Safety outcomes and near-adult height gain of growth hormone-treated children with SHOX deficiency: data from an observational study and a clinical trial","volume":"87","author":"Benabbad","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"2021051713001937000_6.3.E372.6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ghir.2011.09.004","article-title":"The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age","volume":"21","author":"Kappelgaard","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"2021051713001937000_6.3.E372.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3888"},{"key":"2021051713001937000_6.3.E372.8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12325-008-0101-3","article-title":"Growth hormone treatment for short stature in children born small for gestational age","volume":"25","author":"Jung","year":"2008","journal-title":"Adv Ther"},{"key":"2021051713001937000_6.3.E372.9","doi-asserted-by":"crossref","unstructured":"Hodson EM Willis NS Craig JC (2012) Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev (2):CD003264.","DOI":"10.1002\/14651858.CD003264.pub3"},{"key":"2021051713001937000_6.3.E372.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7157"},{"key":"2021051713001937000_6.3.E372.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6065\/apem.2014.19.1.1","article-title":"Growth hormone treatment in non-growth hormone-deficient children","volume":"19","author":"Loche","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2021051713001937000_6.3.E372.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2882"},{"key":"2021051713001937000_6.3.E372.13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE.15.0873"},{"key":"2021051713001937000_6.3.E372.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.11.3990"},{"key":"2021051713001937000_6.3.E372.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0178"},{"key":"2021051713001937000_6.3.E372.16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000444124","article-title":"Assessment of primary cancer incidence in growth hormone-treated children: comparison of a multinational prospective observational study with population databases","volume":"85","author":"Child","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"2021051713001937000_6.3.E372.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.02.028"},{"key":"2021051713001937000_6.3.E372.18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1017"},{"key":"2021051713001937000_6.3.E372.19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000452887","article-title":"Baseline characteristics and gender differences in prepubertal children treated with growth hormone in Europe, USA, and Japan: 25 years\u2019 KIGS experience\u00ae (1987\u20132012) and review","volume":"87","author":"Ranke","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"2021051713001937000_6.3.E372.20","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.151S055"},{"key":"2021051713001937000_6.3.E372.21","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1210\/jc.2017-00214","article-title":"Mortality in children receiving growth hormone treatment of growth disorders: data from the Genetics and Neuroendocrinology of Short Stature International Study","volume":"102","author":"Quigley","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2021051713001937000_6.3.E372.22","first-page":"1301","article-title":"Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy","volume":"112","author":"Guyda","year":"1975","journal-title":"Can Med Assoc J"},{"key":"2021051713001937000_6.3.E372.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.5.1693"},{"key":"2021051713001937000_6.3.E372.24","unstructured":"Guyda H Dean H (1987) in Clinical use of growth hormone: present and future aspects, Intermittent GH administration in growth hormone deficiency, in Proceedings of the 2nd meeting of the International Growth and Development Association (IGDA) (May 1986, Taormina on Sea), eds Laron Z Butenault O Raiti S (S. Karger, New York), pp 1661\u201371."},{"key":"2021051713001937000_6.3.E372.25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40618-015-0418-0","article-title":"Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study","volume":"39","author":"Cappa","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"2021051713001937000_6.3.E372.26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.anpedi.2015.05.002","article-title":"Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain [article in Spanish]","volume":"84","author":"Luzuriaga Tom\u00e1s","year":"2016","journal-title":"An Pediatr (Barc)"},{"key":"2021051713001937000_6.3.E372.27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1507\/endocrj.EJ11-0386","article-title":"An observational study of the effectiveness and safety of growth hormone (Humatrope(\u00ae)) treatment in Japanese children with growth hormone deficiency or Turner syndrome","volume":"60","author":"Tai","year":"2013","journal-title":"Endocr J"},{"key":"2021051713001937000_6.3.E372.28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1515\/jpem.2011.212","article-title":"Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database","volume":"24","author":"Fujieda","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021051713001937000_6.3.E372.29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0509"},{"key":"2021051713001937000_6.3.E372.30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.1.45"},{"key":"2021051713001937000_6.3.E372.31","unstructured":"Preece MA (1994) in Pediatric nephrology, Evaluation of growth and development, eds Holliday MA Barratt TM Avner ED (Williams & Wilkins, Baltimore), 3rd ed, pp 378\u201396."},{"key":"2021051713001937000_6.3.E372.32","doi-asserted-by":"publisher","DOI":"10.1136\/adc.45.239.13"},{"key":"2021051713001937000_6.3.E372.33","doi-asserted-by":"publisher","DOI":"10.1136\/adc.44.235.291"},{"key":"2021051713001937000_6.3.E372.34","unstructured":"(2011) Guidance documents for industry \u2014 reporting adverse reactions to marketed health products (Health Canada, Ottawa) Available: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/reports-publications\/medeffect-canada\/guidance-document-industry-reporting-adverse-reactions-marketed-health-products-health-canada-2011.html . accessed 2017 Sept 7."},{"key":"2021051713001937000_6.3.E372.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005669"},{"key":"2021051713001937000_6.3.E372.36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.7.2439"},{"key":"2021051713001937000_6.3.E372.37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000157877","article-title":"Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome","volume":"70","author":"Khatchadourian","year":"2008","journal-title":"Horm Res"},{"key":"2021051713001937000_6.3.E372.38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.5.2033"},{"key":"2021051713001937000_6.3.E372.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.7.3136"},{"key":"2021051713001937000_6.3.E372.40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/cen.12848","article-title":"Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency","volume":"83","author":"Berglund","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021051713001937000_6.3.E372.41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1200\/JCO.2001.19.2.480","article-title":"Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control","volume":"19","author":"Packer","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021051713001937000_6.3.E372.42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4159"},{"key":"2021051713001937000_6.3.E372.43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1002"},{"key":"2021051713001937000_6.3.E372.44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2046"},{"key":"2021051713001937000_6.3.E372.45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0656"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20180020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:01:32Z","timestamp":1621281692000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20180020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9,10]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.9778\/cmajo.20180020"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20180020","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}